KKR Goes Surgical: Snags Indian Medical Devices Company Healthium From Apax

Zinger Key Points
  • KKR signs definitive agreements to acquire Healthium Medtech Ltd. from Apax Partners, expanding its global healthcare portfolio.
  • The deal is reportedly valued at INR70 billion ($838.60 million) and is set to close in Q3 2024 pending regulatory approvals.

KKR & Co. Inc. KKR announced the signing of definitive agreements to acquire Healthium Medtech Ltd. from an affiliate of Funds advised by Apax Partners LLP. Financial details were not disclosed.

Based in India, Healthium is a medical devices company that develops, manufactures, and sells a broad range of surgical products worldwide.

Akshay Tanna, Partner and Head of India Private Equity at KKR, said: “Under the leadership of Anish and his talented management team, Healthium has established itself as a leading homegrown producer of medical devices with a strong track record of delivering quality products and a wide distribution network both in India and globally. We look forward to leveraging our global network and healthcare expertise to accelerate its growth in this fast-growing sector and further scale its global business through organic and inorganic growth strategies.”

The transaction, which is subject to receipt of certain regulatory approvals, is projected to close in the third quarter of 2024. 

Citing sources having direct knowledge of the matter, Reuters reported that the deal is valued at INR70 billion ($838.60 million).

As of the quarter-end, KKR’s cash and investments stood at $14.6 billion.

Investors can gain exposure to the stock via Northern Lights Fund Trust IV FMC Excelsior Focus Equity ETF FMCX and EA Series Trust WHITEWOLF Publicly Listed Private Equity ETF LBO.

Also ReadPG&E Nears Deal To Sell Stake To KKR

Price Action: KKR shares closed lower by 2.18% at $95.01 on Friday.

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs
Posted In: EquitiesLarge CapM&ANewsMediaBriefsEurasiaStories That Matter
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!